UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biochemical detection of left-ventricular systolic dysfunction

The Lancet (British edition), 1998-01, Vol.351 (9095), p.9-13

1998

Volltextzugriff (PDF)

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES

Journal of the American College of Cardiology, 2007-02, Vol.49 (6), p.687-694

2007

Volltextzugriff (PDF)

Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure

European journal of heart failure, 2006-06, Vol.8 (4), p.355-360

2006

Volltextzugriff (PDF)

Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy

Journal of hypertension, 1993-10, Vol.11 (10), p.1083-1088

1993

Volltextzugriff (PDF)

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

British heart journal, 2001-07, Vol.86 (1), p.21-26

2001

Volltextzugriff (PDF)

N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure

British heart journal, 2003-08, Vol.89 (8), p.879-881

2003

Volltextzugriff (PDF)

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy

The American heart journal, 1999-12, Vol.138 (6), p.1126-1132

1999

Volltextzugriff (PDF)

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

Heart (British Cardiac Society), 1999-07, Vol.82 (1), p.57-61

1999

Volltextzugriff (PDF)

Plasma endothelin in chronic heart failure

Circulation (New York, N.Y.), 1992-04, Vol.85 (4), p.1374-1379

1992

Volltextzugriff (PDF)

Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery

Heart (British Cardiac Society), 2006-03, Vol.92 (3), p.401-402

2006

Volltextzugriff (PDF)

Multicenter analytical performance evaluation of the Elecsys® proBNP assay

Clinical chemistry and laboratory medicine, 2004-01, Vol.42 (8), p.965-972

2004

Volltextzugriff (PDF)

Enhanced Pressor Response to Angiotensin I in Normotensive Men With the Deletion Genotype (DD) for Angiotensin-Converting Enzyme

Hypertension (Dallas, Tex. 1979), 1995-06, Vol.25 (6), p.1266-1269

1995

Volltextzugriff (PDF)

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (Enalaprilat) in humans

Circulation (New York, N.Y.), 1998-11, Vol.98 (20), p.2148-2153

1998

Volltextzugriff (PDF)

N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation

Heart (British Cardiac Society), 2006-01, Vol.92 (1), p.121-123

2006

Volltextzugriff (PDF)

Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure

Heart (British Cardiac Society), 1999-09, Vol.82 (3), p.352-356

1999

Volltextzugriff (PDF)

Comparison of selective ETA and ETB receptor antagonists in patients with chronic heart failure

European journal of heart failure, 2005-01, Vol.7 (1), p.37-42

2005

Volltextzugriff (PDF)

Human fetal kidney morphometry during gestation and the relationship between weight, kidney morphometry and plasma active renin concentration at birth

Clinical science (1979), 1996-08, Vol.91 (2), p.169-175

1996

Volltextzugriff (PDF)

Neuroendocrine activation and markers of early reperfusion in the acute phase of myocardial infarction

European heart journal, 1993-12, Vol.14 (12), p.1615-1621

1993

Volltextzugriff (PDF)

N-Terminal Brain Natriuretic Peptide, But Not Anemia, Is a Powerful Predictor of Mortality in Advanced Heart Failure

Journal of cardiac failure, 2005-06, Vol.11 (5), p.S47-S53

2005

Volltextzugriff (PDF)

Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat

Diabetes (New York, N.Y.), 2000-12, Vol.49 (12), p.2222-2226

2000

Volltextzugriff (PDF)

Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice

Heart (British Cardiac Society), 1997-12, Vol.78 (6), p.594-597

1997

Volltextzugriff (PDF)

Telemetry for Cardiovascular Monitoring in a Pharmacological Study: New Approaches to Data Analysis

Hypertension (Dallas, Tex. 1979), 1999-01, Vol.33 (1S Suppl), p.248-255

1999

Volltextzugriff (PDF)

Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin

British heart journal, 2003-07, Vol.89 (7), p.789-790

2003

Volltextzugriff (PDF)

Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults

Circulation (New York, N.Y.), 1996-03, Vol.93 (6), p.1148-1154

1996

Volltextzugriff (PDF)

Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans

Journal of hypertension, 2000, Vol.18 (1), p.61-64

2000

Volltextzugriff (PDF)

1 – 25 von 465

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(427)
Mit Volltextzugriff
(309)

Publikationsform

Sprache

Englisch
(465)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biochemical detection of left-ventricular systolic dysfunction

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES

Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure

Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

Plasma endothelin in chronic heart failure

Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery

Multicenter analytical performance evaluation of the Elecsys® proBNP assay

Enhanced Pressor Response to Angiotensin I in Normotensive Men With the Deletion Genotype (DD) for Angiotensin-Converting Enzyme

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (Enalaprilat) in humans

N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation

Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure

Comparison of selective ETA and ETB receptor antagonists in patients with chronic heart failure

Human fetal kidney morphometry during gestation and the relationship between weight, kidney morphometry and plasma active renin concentration at birth

Neuroendocrine activation and markers of early reperfusion in the acute phase of myocardial infarction

N-Terminal Brain Natriuretic Peptide, But Not Anemia, Is a Powerful Predictor of Mortality in Advanced Heart Failure

Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat

Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice

Telemetry for Cardiovascular Monitoring in a Pharmacological Study: New Approaches to Data Analysis

Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin

Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults

Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans

Suchergebnisse filtern